PATENT CLAIM ANALYSIS

Application Number: 15984410
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "234200"]

Abstract:
The present invention discloses a novel use of a pharmaceutical composition in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction, in particular to the use of AC1 inhibitor NB001 and AC1&8 mixed inhibitors NB010 and NB011 in the preparation of a medicament in the treatment of opioid-induced tolerance and addiction.

Claim (Index 11):
A pharmaceutical composition for treating an itching response caused by chronic use of morphine, the pharmaceutical composition containing at least one of three compounds of NB001, NB010, or NB011.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.84375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15651564', '12083358', '14239461', '12600503', '14391658']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671912592057242
- 35 USC 102 Novelty (BERT): 0.4989338565585436
- Combined Prediction Score: 0.7403655189410061
- Mean Citation Score: 204.428564
- Max Citation Score: 245.85503
- Similarity Product: 184.0715786166716

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test